| Full Name | Michelle A Allen |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 17 93rd St, Keene, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689116980 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 059642-21 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle A Allen, 64 Main St, Keene, NH 03431-3701 Ph: (603) 283-1570 | Michelle A Allen, 17 93rd St, Keene, NH 03431-3989 Ph: (603) 283-1570 |
News Archive
Drawing on its Jesuit Catholic heritage, Loyola University Chicago Stritch School of Medicine has long understood the importance of reflection in medical education as a key element in physician formation.
The National Patient Safety Foundation, a nonprofit specializing in advancing safe patient care, is creating a groundbreaking new membership program for patient safety professionals that will provide a unique opportunity for sharing of best practices and the unification of the growing patient safety community. New members can join the American Society of Professionals in Patient Safety at NPSF starting in January 2011.
Emerging Healthcare Solutions, Inc. announced today that the Company has signed an option with Regenevita, owner of the right to license Neo Natal Progenitor Cell Expansion Technology in Latin America. The core technology on which the Regenevita technology is based was originally developed by NASA, the National Aeronautics and Space Administration, and was sub-licensed to Regenevita for use with Neo Natal Progenitor Cell Expansion.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to die. The trick: Inactivating a protein that normally helps cells to avoid self-destruction.
› Verified 7 days ago
Bridget Toepfer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 91 Maple Ave, Keene, NH 03431 Phone: 603-358-3384 Fax: 603-357-1242 | |
Dr. Murphy R Neenan, APRN Registered Nurse Medicare: Medicare Enrolled Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 | |
Thomas William Connelly Jr., PHD, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 64 Main St Fl 3, Keene, NH 03431 Phone: 603-283-1570 | |
Mary H Mccarthy, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 40 Avon St, Keene, NH 03431 Phone: 603-357-4400 Fax: 603-357-9648 | |
Carolyn Alice Ogren, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 64 Main St Fl 3, Keene, NH 03431 Phone: 603-357-4400 | |
Katherine B Hubner, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 17 93rd St., Keene, NH 03431 Phone: 603-313-5674 | |
Colleen Anne Walsh-wolterbeek, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 441 Main St, Suite C, Keene, NH 03431 Phone: 603-354-7868 Fax: 603-354-7848 |